Company Supported Sessions
Chair(s)
- Ronnachai Kongsakon, Thailand
Session Description
Role of Long-Acting Injectables (LAI) in The Management of Bipolar Mood Disorder - Supported by Otsuka Pharmaceutical Co., Ltd.
Session description
Dr. Toba (Canada) will take you on a journey of the treatment of bipolar mood disorder. He will describe the burden of bipolar1 disorder and share the implications of non-adherence in the treatment outcome of bipolar 1 disorder. Lastly he will also introduce the role of Long-Acting Injectable antipsychotics to improve treatment outcomes.
Role of Long-Acting Injectables (LAI) in The Management of Bipolar Mood Disorder (ID 3748)
Session Type
Company Supported Sessions
Date
09.03.2021, Tuesday
Session Time
11:00 - 12:00
Room
Meet the Expert
Lecture Time
11:00 - 11:00
Session_Icon
Supported by Otsuka Pharmaceutical Co., Ltd. (ID 3810)
Session Type
Company Supported Sessions
Date
09.03.2021, Tuesday
Session Time
11:00 - 12:00
Room
Meet the Expert
Lecture Time
11:00 - 11:00
Session_Icon
Introduction (ID 3811)
Session Type
Company Supported Sessions
Date
09.03.2021, Tuesday
Session Time
11:00 - 12:00
Room
Meet the Expert
Lecture Time
11:00 - 11:05
Presenter
- Ronnachai Kongsakon, Thailand
Session_Icon
Role of Long-Acting Injectables (LAI) in The Management of Bipolar Mood Disorder (ID 3812)
Session Type
Company Supported Sessions
Date
09.03.2021, Tuesday
Session Time
11:00 - 12:00
Room
Meet the Expert
Lecture Time
11:05 - 11:45
Presenter
- Oloruntoba J. Oluboka, Canada
Session_Icon
Discussion and Q&A (ID 3813)
Session Type
Company Supported Sessions
Date
09.03.2021, Tuesday
Session Time
11:00 - 12:00
Room
Meet the Expert
Lecture Time
11:45 - 12:00
Presenter
- Ronnachai Kongsakon, Thailand
- Oloruntoba J. Oluboka, Canada
Session_Icon